Xenon Pharma’s azetukalner shows 53% seizure reduction in trial

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Xenon presents positive epilepsy drug trial data at AAN meeting Hisse Senetleri 0 1
A Ascendis Pharma’s YUVIWEL gains orphan drug exclusivity in U.S. Hisse Senetleri 0 8
A Form 144 Xenon Pharmaceuticals Inc. For: 13 March Hisse Senetleri 0 15
A Xenon Pharmaceuticals prices $650M public offering at $57/share Hisse Senetleri 0 9
A Redx Pharma’s RXC008 gets FDA fast track for Crohn’s disease Hisse Senetleri 0 11
A Xenon Pharmaceuticals to report epilepsy drug trial results Monday Hisse Senetleri 0 14
A Stifel reiterates Buy rating on Xenon Pharmaceuticals stock amid competitor setback Hisse Senetleri 0 25
A Ian Mortimer, Xenon Pharma CEO, sells $4365 in shares Hisse Senetleri 0 29

Benzer konular

Üst